미쎄라(Mircera) 시장 보고서(2025년) : 역학, 파이프라인 분석, 시장 인사이트 및 예측

Mircera Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

US $ 4,490 ￦ 6,661,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,629,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 12,596,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

미쎄라 시장 규모는 향후 몇 년간 강한 성장을 보일 것으로 예상됩니다. 예측 기간 동안의 성장은 전 세계적으로, 특히 개발도상국에서 암 발병률이 증가할 것으로 예상되고, 신흥 시장을 중심으로 의료비 지출이 지속적으로 증가할 것으로 예상되며, 빈혈을 보다 효과적으로 관리하기 위한 혁신적인 치료 옵션에 대한 수요가 높고, 빈혈 치료에 대한 수요가 증가하고, 미쎄라가 병원과 외래 환자 환경 모두에서 채택될 것으로 예상되기 때문입니다. 예측 기간 동안의 주요 동향으로는 장기간 작용형 ESA에 대한 수요 증가, 기술 발전, 의료 인프라 개발, 만성 신장 질환(CKD) 관리에 대한 채택 증가, 환자 중심 의약품 전달 시스템에 대한 관심 증가 등이 있습니다.

만성 신장 질환(CKD)의 유병률 증가는 앞으로 미쎄라 시장의 성장을 촉진할 것으로 예상됩니다. CKD는 신장 기능이 점진적으로 상실되는 건강 문제이며, 종종 당뇨병 및 고혈압과 같은 질환과 관련이 있습니다. CKD의 발병률이 증가하는 요인은 인구 고령화, 생활 방식의 변화, 진단 기술의 발전 등입니다. 적혈구 생성 호르몬의 생산 감소로 인해 발생하는 CKD의 흔한 합병증인 빈혈을 치료하고 헤모글로빈 수치를 안정적으로 유지하기 위해서는 미쎄라와 같은 적혈구 생성 촉진제가 필요합니다. 예를 들어, 2023년 6월 영국 신장 연구소(Kidney Research UK)에 따르면, 영국에는 약 720만 명의 CKD 환자가 있으며, 2033년에는 그 수가 761만 명으로 증가할 것으로 예상됩니다. 따라서 CKD의 유병률 증가는 미쎄라 시장의 성장을 촉진하고 있습니다.

미쎄라 시장의 주요 동향은 CKD와 관련된 빈혈 치료를 위해, 특히 소아 환자를 위한 승인된 솔루션 개발에 집중하고 있습니다. CKD로 인한 빈혈이 있는 소아 환자는 적혈구 생성을 촉진하는 장기간 작용형 적혈구 생성 촉진제인 미쎄라(메톡시 폴리에틸렌 글리콜-에포에틴 베타)의 혜택을 받을 수 있습니다. 이는 자주 주사를 맞을 필요성을 줄이고 혈액 수혈 위험을 최소화하며 헤모글로빈 수치를 개선해 전반적인 성장과 삶의 질을 향상시킵니다. 예를 들어, 2024년 4월 Vifor Pharma는 미쎄라를 CKD 관련 빈혈 치료에 사용하기 위해 3개월에서 17세 사이의 소아 환자를 대상으로 FDA 승인을 받았습니다. 이 승인은 투석 환자 및 비투석 환자 모두에게 적용되며, 특히 다른 ESA에서 전환하는 환자에게 특히 적용됩니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 바이오의약품 시장에서의 제품 특성

• 분자 유형
• 투여경로(ROA)
• 작용기전(MOA)
• 안전성과 유효성

제4장 시장 동향과 전략

제5장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염, 경기 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제6장 세계의 성장 분석과 전략 분석 프레임워크

• 세계의 미쎄라 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 이용 산업의 분석
• 세계의 미쎄라 시장 : 성장률 분석
• 세계의 미쎄라 시장 실적 : 규모와 성장(2019-2024년)
• 세계의 미쎄라 시장 예측 : 규모와 성장(2024-2029년, 2034년)
• 세계의 미쎄라 : 전체 시장 규모(TAM)

제7장 세계 시장의 가격 분석과 예측

제8장 시장 세분화

• 세계의 미쎄라 시장 : 배합별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 주사액
• 프리필드 주사기
• 세계의 미쎄라 시장 : 적응증별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 만성 신장병에 의한 빈혈
• 암 환자의 빈혈
• 세계의 미쎄라 시장 : 유통 채널별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 병원
• 투석 센터
• 전문 클리닉
• 소매 약국
• 세계의 미쎄라 시장 : 최종 사용자 환자 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 성인 환자
• 노인환자

제9장 임상적응증 세계 시장 역학

• 약제의 부작용
• 임상적응증의 발병률과 유병률

제10장 지역별, 국가별 분석

• 세계의 미쎄라 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 세계의 미쎄라 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 한국 시장

제17장 서유럽 시장

제18장 영국 시장

제19장 독일 시장

제20장 프랑스 시장

제21장 동유럽 시장

제22장 북미 시장

제23장 미국 시장

제24장 캐나다 시장

제25장 남미 시장

제26장 중동 시장

제27장 아프리카 시장

제28장 경쟁 구도와 기업 프로파일

• 미쎄라 시장 : 경쟁 구도
• 미쎄라 시장 : 기업 프로파일
  • Roche

제29장 세계 시장 : 파이프라인 분석

제30장 세계 시장 경쟁 벤치마킹과 대시보드

제31장 주요 인수합병(M&A)

제32장 최근 시장 동향

제33장 시장의 잠재력이 높은 국가, 전략

• 미쎄라 시장(2029년) : 새로운 기회를 제공하는 국가
• 미쎄라 시장(2029년) : 새로운 기회를 제공하는 부문
• 미쎄라 시장(2029년) : 성장 전략
  • 시장 동향에 의한 전략
  • 경쟁 전략

제34장 부록

HBR

영문 목차

영문목차

Mircera is a medication designed to treat anemia associated with chronic kidney disease (CKD) and anemia in cancer patients. As a long-acting erythropoiesis-stimulating agent (ESA), it works by stimulating red blood cell production to maintain healthy hemoglobin levels. Its extended dosing schedule, typically requiring injections once every two to four weeks, makes it convenient for patients.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main formulation types of mircera include injectable solutions and pre-filled syringes. These formulations are used to treat anemia resulting from chronic kidney disease and cancer-related anemia. Mircera is distributed through hospitals, dialysis centers, specialty clinics, and retail pharmacies. The medication serves various end-users, including adult and geriatric patients.

The mircera market research report is one of a series of new reports from The Business Research Company that provides mircera market statistics, including mircera industry global market size, regional shares, competitors with a mircera market share, detailed mircera market segments, market trends and opportunities, and any further data you may need to thrive in the mircera industry. This mircera market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The mircera market size is expected to see strong growth in the next few years. It will grow to $3,506.3 million in 2029 at a compound annual growth rate (CAGR) of 5%. The growth in the forecast period can be attributed to the expected rise in the global cancer burden, particularly in developing regions, continued increase in healthcare expenditure, particularly in emerging markets, high demand for innovative treatment options to manage anemia more effectively, increasing demand for anemia treatments, adoption of Mircera in both hospital and outpatient settings. Major trends in the forecast period include rising demand for long-acting ESAs, technological advancements, healthcare infrastructure development, increasing adoption in chronic kidney disease (CKD) management, and increasing focus on patient-centric drug delivery systems.

The rising prevalence of chronic kidney disease (CKD) is expected to propel the growth of the mircera market going forward. CKD is a health concern characterized by the gradual loss of kidney function, often associated with conditions such as diabetes and hypertension. The increasing incidence of CKD is driven by factors such as aging populations, lifestyle changes, and improved diagnostic practices. Anemia, a common complication of CKD caused by reduced erythropoietin production, necessitates the use of erythropoiesis-stimulating agents like Mircera to manage and stabilize hemoglobin levels. For instance, in June 2023, according to Kidney Research UK, approximately 7.2 million people in the UK are living with CKD, and by 2033, the number is expected to rise to 7.61 million. Therefore, the rising prevalence of CKD drives the growth of the mircera market.

A key trend in the mircera market is focusing on developing approved solutions, particularly for pediatric patients, for the treatment of anemia associated with CKD. Pediatric patients with anemia due to CKD can benefit from Mircera (methoxy polyethylene glycol-epoetin beta), a long-acting erythropoiesis-stimulating agent that helps stimulate red blood cell production. This reduces the need for frequent injections, minimizes the risk of blood transfusions, and improves hemoglobin levels, enhancing overall growth and quality of life. For instance, in April 2024, Vifor Pharma received FDA approval to include pediatric patients aged 3 months to 17 years for Mircera's use in treating CKD-related anemia. This approval applies to both dialysis and non-dialysis patients, especially those transitioning from another ESA.

In August 2022, CSL Limited, an Australia-based biotechnology company, acquired Vifor Pharma, the developer of Mircera. This acquisition aims to expand CSL's presence in the nephrology space and enhance its portfolio of treatments for anemia in CKD patients.

The Key player operating in the mircera market is Roche

North America was the largest region in the mircera market in 2024. The regions covered in mircera report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the mircera market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The mircera market consists of sales of solutions and pre-filled syringes designed to treat anemia caused by chronic kidney disease (CKD). Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Mircera Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on mircera market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 10 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-4 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for mircera ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The mircera market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Formulation: Injectable Solution; Pre-filled Syringes
• 2) By Indication: Anemia Due to Chronic Kidney Disease; Anemia in Cancer Patients
• 3) By Distribution Channel: Hospitals; Dialysis Centers; Specialty Clinics; Retail Pharmacies
• 4) By End User Patients: Adult Patients; Geriatric Patients
• Companies Mentioned: Roche
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Mircera Market Characteristics

3. Mircera Market Biologic Drug Characteristics

• 3.1. Molecule Type
• 3.2. Route Of Administration (ROA)
• 3.3. Mechanism Of Action (MOA)
• 3.4. Safety And Efficacy

4. Mircera Market Trends And Strategies

5. Mircera Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

6. Global Mircera Growth Analysis And Strategic Analysis Framework

• 6.1. Global Mircera PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 6.2. Analysis Of End Use Industries
• 6.3. Global Mircera Market Growth Rate Analysis
• 6.4. Global Mircera Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 6.5. Global Mircera Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 6.6. Global Mircera Total Addressable Market (TAM)

7. Global Mircera Market Pricing Analysis & Forecasts

8. Mircera Market Segmentation

• 8.1. Global Mircera Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injectable Solution
• Pre-filled Syringes
• 8.2. Global Mircera Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Anemia Due to Chronic Kidney Disease
• Anemia in Cancer Patients
• 8.3. Global Mircera Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Dialysis Centers
• Specialty Clinics
• Retail Pharmacies
• 8.4. Global Mircera Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Adult Patients
• Geriatric Patients

9. Global Mircera Market Epidemiology Of Clinical Indications

• 9.1. Drug Side Effects
• 9.2. Incidence And Prevalence of Clinical Indications

10. Mircera Market Regional And Country Analysis

• 10.1. Global Mircera Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. Global Mircera Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Asia-Pacific Mircera Market

• 11.1. Asia-Pacific Mircera Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Mircera Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Asia-Pacific Mircera Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Asia-Pacific Mircera Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. China Mircera Market

• 12.1. China Mircera Market Overview
• 12.2. China Mircera Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 12.3. China Mircera Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 12.4. China Mircera Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

13. India Mircera Market

• 13.1. India Mircera Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. India Mircera Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. India Mircera Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. Japan Mircera Market

• 14.1. Japan Mircera Market Overview
• 14.2. Japan Mircera Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. Japan Mircera Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. Japan Mircera Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Australia Mircera Market

• 15.1. Australia Mircera Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.2. Australia Mircera Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Australia Mircera Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. South Korea Mircera Market

• 16.1. South Korea Mircera Market Overview
• 16.2. South Korea Mircera Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. South Korea Mircera Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.4. South Korea Mircera Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Western Europe Mircera Market

• 17.1. Western Europe Mircera Market Overview
• 17.2. Western Europe Mircera Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Western Europe Mircera Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.4. Western Europe Mircera Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. UK Mircera Market

• 18.1. UK Mircera Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. UK Mircera Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. UK Mircera Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Germany Mircera Market

• 19.1. Germany Mircera Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Germany Mircera Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Germany Mircera Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. France Mircera Market

• 20.1. France Mircera Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. France Mircera Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. France Mircera Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Mircera Market

• 21.1. Eastern Europe Mircera Market Overview
• 21.2. Eastern Europe Mircera Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Mircera Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Mircera Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. North America Mircera Market

• 22.1. North America Mircera Market Overview
• 22.2. North America Mircera Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. North America Mircera Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.4. North America Mircera Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. USA Mircera Market

• 23.1. USA Mircera Market Overview
• 23.2. USA Mircera Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. USA Mircera Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. USA Mircera Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. Canada Mircera Market

• 24.1. Canada Mircera Market Overview
• 24.2. Canada Mircera Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. Canada Mircera Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. Canada Mircera Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. South America Mircera Market

• 25.1. South America Mircera Market Overview
• 25.2. South America Mircera Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. South America Mircera Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. South America Mircera Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. Middle East Mircera Market

• 26.1. Middle East Mircera Market Overview
• 26.2. Middle East Mircera Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. Middle East Mircera Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. Middle East Mircera Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Africa Mircera Market

• 27.1. Africa Mircera Market Overview
• 27.2. Africa Mircera Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Africa Mircera Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.4. Africa Mircera Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Mircera Market Competitive Landscape And Company Profiles

• 28.1. Mircera Market Competitive Landscape
• 28.2. Mircera Market Company Profiles
  • 28.2.1. Roche Overview, Products and Services, Strategy and Financial Analysis

29. Global Mircera Market Pipeline Analysis

• 29.1. High Level Clinic Trail Information

30. Global Mircera Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Mircera Market

32. Recent Developments In The Mircera Market

33. Mircera Market High Potential Countries, Segments and Strategies

• 33.1 Mircera Market In 2029 - Countries Offering Most New Opportunities
• 33.2 Mircera Market In 2029 - Segments Offering Most New Opportunities
• 33.3 Mircera Market In 2029 - Growth Strategies
  • 33.3.1 Market Trend Based Strategies
  • 33.3.2 Competitor Strategies

34. Appendix

• 34.1. Abbreviations
• 34.2. Currencies
• 34.3. Historic And Forecast Inflation Rates
• 34.4. Research Inquiries
• 34.5. The Business Research Company
• 34.6. Copyright And Disclaimer